No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.

<h4>Background</h4>Xenotropic murine leukemia virus-related virus (XMRV), a novel human retrovirus originally identified in prostate cancer tissues, has recently been associated with chronic fatigue syndrome (CFS), a disabling disease of unknown etiology affecting millions of people worl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Oliver Hohn, Kristin Strohschein, Alexander U Brandt, Sandra Seeher, Sandra Klein, Reinhard Kurth, Friedemann Paul, Christian Meisel, Carmen Scheibenbogen, Norbert Bannert
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c95b828300c94a3f829668445e0ec57c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c95b828300c94a3f829668445e0ec57c
record_format dspace
spelling oai:doaj.org-article:c95b828300c94a3f829668445e0ec57c2021-11-18T07:01:21ZNo evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.1932-620310.1371/journal.pone.0015632https://doaj.org/article/c95b828300c94a3f829668445e0ec57c2010-12-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21203514/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Xenotropic murine leukemia virus-related virus (XMRV), a novel human retrovirus originally identified in prostate cancer tissues, has recently been associated with chronic fatigue syndrome (CFS), a disabling disease of unknown etiology affecting millions of people worldwide. However, several subsequent studies failed to detect the virus in patients suffering from these illnesses or in healthy subjects. Here we report the results of efforts to detect antibody responses and viral sequences in samples from a cohort of German CFS and relapsing remitting multiple sclerosis (MS) patients with fatigue symptoms.<h4>Methodology</h4>Blood samples were taken from a cohort of 39 patients fulfilling the Fukuda/CDC criteria (CFS), from 112 patients with an established MS diagnosis and from 40 healthy donors. Fatigue severity in MS patients was assessed using the Fatigue Severity Scale (FSS). Validated Gag- and Env-ELISA assays were used to screen sera for XMRV antibodies. PHA-activated PBMC were cultured for seven days in the presence of IL-2 and DNA isolated from these cultures as well as from co-cultures of PBMC and highly permissive LNCaP cells was analyzed by nested PCR for the presence of the XMRV gag gene. In addition, PBMC cultures were exposed to 22Rv1-derived XMRV to assess infectivity and virus production.<h4>Conclusion</h4>None of the screened sera from CFS and MS patients or healthy blood donors tested positive for XMRV specific antibodies and all PBMC (and PBMC plus LNCaP) cultures remained negative for XMRV sequences by nested PCR. These results argue against an association between XMRV infection and CFS and MS in Germany. However, we could confirm that PBMC cultures from healthy donors and from CFS patients can be experimentally infected by XMRV, resulting in the release of low levels of transmittable virus.Oliver HohnKristin StrohscheinAlexander U BrandtSandra SeeherSandra KleinReinhard KurthFriedemann PaulChristian MeiselCarmen ScheibenbogenNorbert BannertPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 12, p e15632 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Oliver Hohn
Kristin Strohschein
Alexander U Brandt
Sandra Seeher
Sandra Klein
Reinhard Kurth
Friedemann Paul
Christian Meisel
Carmen Scheibenbogen
Norbert Bannert
No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.
description <h4>Background</h4>Xenotropic murine leukemia virus-related virus (XMRV), a novel human retrovirus originally identified in prostate cancer tissues, has recently been associated with chronic fatigue syndrome (CFS), a disabling disease of unknown etiology affecting millions of people worldwide. However, several subsequent studies failed to detect the virus in patients suffering from these illnesses or in healthy subjects. Here we report the results of efforts to detect antibody responses and viral sequences in samples from a cohort of German CFS and relapsing remitting multiple sclerosis (MS) patients with fatigue symptoms.<h4>Methodology</h4>Blood samples were taken from a cohort of 39 patients fulfilling the Fukuda/CDC criteria (CFS), from 112 patients with an established MS diagnosis and from 40 healthy donors. Fatigue severity in MS patients was assessed using the Fatigue Severity Scale (FSS). Validated Gag- and Env-ELISA assays were used to screen sera for XMRV antibodies. PHA-activated PBMC were cultured for seven days in the presence of IL-2 and DNA isolated from these cultures as well as from co-cultures of PBMC and highly permissive LNCaP cells was analyzed by nested PCR for the presence of the XMRV gag gene. In addition, PBMC cultures were exposed to 22Rv1-derived XMRV to assess infectivity and virus production.<h4>Conclusion</h4>None of the screened sera from CFS and MS patients or healthy blood donors tested positive for XMRV specific antibodies and all PBMC (and PBMC plus LNCaP) cultures remained negative for XMRV sequences by nested PCR. These results argue against an association between XMRV infection and CFS and MS in Germany. However, we could confirm that PBMC cultures from healthy donors and from CFS patients can be experimentally infected by XMRV, resulting in the release of low levels of transmittable virus.
format article
author Oliver Hohn
Kristin Strohschein
Alexander U Brandt
Sandra Seeher
Sandra Klein
Reinhard Kurth
Friedemann Paul
Christian Meisel
Carmen Scheibenbogen
Norbert Bannert
author_facet Oliver Hohn
Kristin Strohschein
Alexander U Brandt
Sandra Seeher
Sandra Klein
Reinhard Kurth
Friedemann Paul
Christian Meisel
Carmen Scheibenbogen
Norbert Bannert
author_sort Oliver Hohn
title No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.
title_short No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.
title_full No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.
title_fullStr No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.
title_full_unstemmed No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.
title_sort no evidence for xmrv in german cfs and ms patients with fatigue despite the ability of the virus to infect human blood cells in vitro.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/c95b828300c94a3f829668445e0ec57c
work_keys_str_mv AT oliverhohn noevidenceforxmrvingermancfsandmspatientswithfatiguedespitetheabilityofthevirustoinfecthumanbloodcellsinvitro
AT kristinstrohschein noevidenceforxmrvingermancfsandmspatientswithfatiguedespitetheabilityofthevirustoinfecthumanbloodcellsinvitro
AT alexanderubrandt noevidenceforxmrvingermancfsandmspatientswithfatiguedespitetheabilityofthevirustoinfecthumanbloodcellsinvitro
AT sandraseeher noevidenceforxmrvingermancfsandmspatientswithfatiguedespitetheabilityofthevirustoinfecthumanbloodcellsinvitro
AT sandraklein noevidenceforxmrvingermancfsandmspatientswithfatiguedespitetheabilityofthevirustoinfecthumanbloodcellsinvitro
AT reinhardkurth noevidenceforxmrvingermancfsandmspatientswithfatiguedespitetheabilityofthevirustoinfecthumanbloodcellsinvitro
AT friedemannpaul noevidenceforxmrvingermancfsandmspatientswithfatiguedespitetheabilityofthevirustoinfecthumanbloodcellsinvitro
AT christianmeisel noevidenceforxmrvingermancfsandmspatientswithfatiguedespitetheabilityofthevirustoinfecthumanbloodcellsinvitro
AT carmenscheibenbogen noevidenceforxmrvingermancfsandmspatientswithfatiguedespitetheabilityofthevirustoinfecthumanbloodcellsinvitro
AT norbertbannert noevidenceforxmrvingermancfsandmspatientswithfatiguedespitetheabilityofthevirustoinfecthumanbloodcellsinvitro
_version_ 1718424070189481984